AB Corporate Bond ETF (NASDAQ:EYEG) Short Interest Update

AB Corporate Bond ETF (NASDAQ:EYEG) saw a significant growth in short interest in July. As of July 31st, there was short interest totaling 655 shares, a growth of 568.4% from the July 15th total of 98 shares. Based on an average trading volume of 295 shares, the short-interest ratio is presently 2.2 days. Approximately 0.0% of the company’s shares are short sold.

Institutional Investors Weigh In On AB Corporate Bond ETF

A hedge fund recently bought a new stake in AB Corporate Bond ETF stock. Kestra Advisory Services LLC bought a new stake in shares of AB Corporate Bond ETF (NASDAQ:EYEG) during the 4th quarter, according to its most recent filing with the SEC. The firm bought 951 shares of the specialty pharmaceutical company’s stock, valued at approximately $34,000. Kestra Advisory Services LLC owned 0.13% of AB Corporate Bond ETF as of its most recent filing with the SEC. Hedge funds and other institutional investors own 64.16% of the company’s stock.

AB Corporate Bond ETF Stock Up 0.2%

Shares of NASDAQ:EYEG traded up $0.06 during midday trading on Wednesday, hitting $34.57. 259 shares of the company’s stock traded hands, compared to its average volume of 252. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.07 and a current ratio of 3.07. The company has a market cap of $27.66 million, a PE ratio of -20.58 and a beta of 0.18. The firm’s fifty day moving average price is $34.98 and its two-hundred day moving average price is $35.30. AB Corporate Bond ETF has a twelve month low of $34.46 and a twelve month high of $36.63.

AB Corporate Bond ETF Increases Dividend

The business also recently disclosed a monthly dividend, which was paid on Thursday, August 6th. Shareholders of record on Monday, August 3rd were given a $0.1427 dividend. This represents a c) annualized dividend and a yield of 5.0%. This is a boost from AB Corporate Bond ETF’s previous monthly dividend of $0.14. The ex-dividend date of this dividend was Monday, August 3rd. AB Corporate Bond ETF’s dividend payout ratio is -102.38%.

AB Corporate Bond ETF Company Profile

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.